The novel vaccination is recommended as an option for adults aged 65 years and older who have not received a pneumococcal conjugate vaccine.

The risk for developing CVD and T2D was highest among individuals who frequently experienced the behavior in the workplace, according to new study.

Neurocrine Biosciences made the announcement and said, if approved in December, crinecerfont will be the first new treatment and treatment approach to CAH in 70 years.

Your daily dose of the clinical news you may have missed.

After a 5-year trial, the company is ending its entry into health care, citing the lack of a "sustainable business model."

Individuals 6 months and older should receive updated COVID-19 and influenza vaccines for the 2024-2025 respiratory virus season, the agency recommended.

Your daily dose of the clinical news you may have missed.

After performing a back blow maneuver on her 10-month-old daughter to dislodge a popcorn kernel, a mother arrives at the ED with the child in distress. What happened?

The expert panel concludes by examining strategies for managing hypoglycemia challenges related to dumping syndrome, particularly in the context of continuous glucose monitoring use.

The key opinion leaders explore strategies for incorporating continuous glucose monitoring into primary care diabetes management, highlighting essential takeaways from their comprehensive discussion.

Medical experts analyze the case of a 78-year-old woman with diabetes, evaluating the impact of continuous glucose monitoring on her treatment outcomes and overall diabetes management.

The panelists discuss the selection criteria for continuous glucose monitoring (CGM) candidates, identifying patient groups who would derive the greatest benefit from CGM use and those at higher risk of complications without such monitoring.

Key opinion leaders explore the advantages of remote medication adjustments facilitated by distant patient monitoring and the ability to view glucose data from afar, enhancing diabetes care management.

Medical experts in diabetes management examine a real-world case study, providing valuable insights into the clinical impact of continuous glucose monitoring systems and their role in enhancing patient management strategies.

The panel analyzes various continuous glucose monitoring (CGM) methods, detailing the advantages of each approach and sharing their preferred CGM systems for optimal patient care.

Key opinion leaders emphasize the significance of continuous glucose monitoring for diabetes patients, underscoring its advantages in enhancing physician practices and improving patient care strategies.

Key opinion leaders in the management of diabetes delineate the definition of older patients and examine the implications of homeostenosis, a condition that disrupts homeostatic mechanisms in aging individuals.

The committee endorsed a universal recommendation for a single lifetime dose of RSV vaccine for adults aged ≥75 years and a risk-based recommendation for those aged 60 to 74 years.

ADA 2024. Adults started on the Omnipod 5 AID system had an A1c reduction from 8.2% at baseline to 7.4% at 13 weeks, researchers report.

Your daily dose of the clinical news you may have missed.

The dual PDE3/PDE4 inhibitor is the first inhaled product with a novel mechanism of action approved for COPD in 2 decades and is delivered via standard jet nebulizer.

Medha Munshi, MD, and Javier Morales, MD, FACP, FACE, emphasize the significance of personalized diabetes management, emphasizing age and other patient-specific factors as crucial considerations for optimizing care.

ADA 2024. Adults using more antihypertensive medications had higher odds for hypercortisolism, according to new data from the CATALYST phase 4 study.

Your daily dose of the clinical news you may have missed.

This quick quiz tests what you know about updates to the 2024 ADA standards of care, which include guidance on antiobesity drugs and managing comorbid chronic disease.